|
Secondary prevention
Citations 1-10 of 240 total displayed.
|
Most recent content
(1 Dec 2009):
|
- Comments, Opinions, and Reviews
Systematic Review of the Perioperative Risks of Stroke or Death After Carotid Angioplasty and Stenting
- Emmanuel Touzé, Ludovic Trinquart, Gilles Chatellier, and Jean-Louis Mas
Stroke 2009;40:e683-693e; published online before print as doi:10.1161/STROKEAHA.109.562041
[Abstract]
[Full text]
- Research Letters
A Systematic Review of Angiotensin Receptor Blockers in Preventing Stroke
- Guo-Cai Lu, Jin-Wei Cheng, Ke-Ming Zhu, Xiu-Juan Ma, Fu-Ming Shen, and Ding-Feng Su
Stroke 2009;40:3876-3878; published online before print as doi:10.1161/STROKEAHA.109.559989
[Abstract]
[Full text]
|
Past content
(since Jun 2001):
|
- Articles
Systematic Review of the Perioperative Risks of Stroke or Death After Carotid Angioplasty and Stenting
- Emmanuel Touzé, Ludovic Trinquart, Gilles Chatellier, and Jean-Louis Mas
Stroke published November 5, 2009, doi:10.1161/STROKEAHA.109.562041
[Abstract]
- Articles
A Systematic Review of Angiotensin Receptor Blockers in Preventing Stroke
- Guo-Cai Lu, Jin-Wei Cheng, Ke-Ming Zhu, Xiu-Juan Ma, Fu-Ming Shen, and Ding-Feng Su
Stroke published November 5, 2009, doi:10.1161/STROKEAHA.109.559989
[Abstract]
- Research Letters
Cerebral Microbleeds in Ischemic Stroke Patients on Warfarin Treatment
- Dilek Necioglu Orken, Gulay Kenangil, Ender Uysal, and Hulki Forta
Stroke 2009;40:3638-3640; published online before print as doi:10.1161/STROKEAHA.109.559450
[Abstract]
[Full text]
- Topical Review
Pharmacogenetics and Stroke
- James F. Meschia
Stroke 2009;40:3641-3645; published online before print as doi:10.1161/STROKEAHA.109.562231
[Abstract]
[Full text]
- Articles
Pharmacogenetics and Stroke
- James F. Meschia
Stroke published September 17, 2009, doi:10.1161/STROKEAHA.109.562231
[Abstract]
- Articles
Cerebral Microbleeds in Ischemic Stroke Patients on Warfarin Treatment
- Dilek Necioglu Orken, Gulay Kenangil, Ender Uysal, and Hulki Forta
Stroke published September 17, 2009, doi:10.1161/STROKEAHA.109.559450
[Abstract]
- Controversies in Stroke
Angiotensin Receptor Blockers Should Be Regarded as First-Line Drugs for Stroke Prevention in Both Primary and Secondary Prevention Settings: No
- Martin H. Strauss and Alistair Hall
Stroke 2009;40:3161-3162; published online before print as doi:10.1161/STROKEAHA.109.559062
[Full text]
- Original Contributions
Patients Enrolled in Large Randomized Clinical Trials of Antiplatelet Treatment for Prevention After Transient Ischemic Attack or Ischemic Stroke Are Not Representative of Patients in Clinical Practice: The Netherlands Stroke Survey
- Lisette Maasland, Robert J. van Oostenbrugge, Cees F. Franke, Wilma J.M. Scholte op Reimer, Peter J. Koudstaal, Diederik W.J. Dippel for the Netherlands Stroke Survey Investigators
Stroke 2009;40:2662-2668; published online before print as doi:10.1161/STROKEAHA.109.551812
[Abstract]
[Full text]
|
|
